Adcendo Series C: $75 Million Series C Financing to Continue Advancing First- and Best-in-class Clinical ADC Pipeline
HQ: DK
Founded: 2017
Series C
Sector: BioTech, Pharmaceutical
Investment Raised: USD 75m €
Valuation Remains Undisclosed
Investors: The round was led Jeito Capital, with participation from additional new investors Vida Ventures, BPI France, and EIFO (Export and Investment Fund of Denmark), as well as all existing investors, including TCGX, RA Capital Management, TPG, Orbimed, Venrock, Surveyor, Logos Capital, Novo Holdings, Pontifax Venture Capital, Dawn Biopharma, a platform controlled by KKR, HealthCap, Gilde Healthcare and Ysios Capital.
Ori Biotech raises over $100 million in Series B funding to launch innovative cell and gene therapy manufacturing platform
HQ: UK
Founded: 2015
Series B
Sector: BioTech
Investment Raised: USD 100M €
Valuation Remains Undisclosed
Investors: Novalis LifeSciences Puhua Capital Chimera Abu Dhabi Amadeus Capital Partners (https://www.amadeuscapital.com/) Delin Ventures (https://www.delinventures.com/) Northpond Ventures Octopus Ventures (https://octopusventures.com/)
Quell Therapeutics raises $156m in oversubscribed Series B
HQ: UK
Founded: 2019
Series B
Sector: BioTech
Investment Raised: USD 156M €
Valuation Remains Undisclosed
Investors: Jeito Capital (https://www.jeito.life/en/home/) Ridgeback Capital Investments (http://www.ridgebackcap.com/) SV Health Investors (https://svhealthinvestors.com/) Fidelity Management & Research Company LLC (http://www.fidelity.com) Syncona (https://www.synconaltd.com/) British Patient Capital through its Future Fund.
GV-backed Cambridge Epigenetix lines up USD 88M to roll out genetic sequencing technology
HQ: UK
Founded: 2012
Series D
Sector: BioTech
Investment Raised: USD 88M €
Valuation Remains Undisclosed
Investors: Third Point (https://www.thirdpoint.com/) Temasek Holdings (https://www.temasek.com.sg/en/index) Sequoia Capital (https://www.sequoiacap.com/) New Science Ventures (https://www.newscienceventures.com/) Ahren Innovation Capital (https://www.ahreninnovationcapital.com/)
Novadip raises USD 22M in series B funding for US trial of bone regeneration therapy
HQ: BE
Founded: 2013
Series B
Sector: BioTech
Investment Raised: USD 22M €
Valuation Remains Undisclosed
Investors: Vives Louvain Technology Fund (https://www.vivesfund.com/en) SRIW Life Sciences (https://www.sriw.be/en/our-team/) New Science Ventures (https://www.newscienceventures.com/) Investsud Fund+ CR-CP Life Science Fund (https://www.crunchbase.com/organization/cr-cp-life-science-fund)
Leucid Bio raises GBP 11.5M in Series A financing to develop next generation of innovative chimeric antigen receptor T cell (CAR-T) therapies
HQ: UK
Founded: 2014
Series A
Sector: BioTech
Investment Raised: GBP 11.5M €
Valuation Remains Undisclosed
Investors: Vulpes Investment Management Pte LTD (https://vulpesinvest.com/) Sofinnova Partners (https://www.sofinnovapartners.com/) Epidarex Capital (https://epidarex.com/) British Business Bank (https://www.british-business-bank.co.uk/) 2invest (https://2invest-ag.com/)
Animal-free cheese producer Formo raises USD 50M in Series A funding round
HQ: DE
Founded: 2018
Series A
Sector: BioTech
Investment Raised: USD 50M €
Valuation Remains Undisclosed
Investors: M Ventures (https://www.m-ventures.com/) Lowercarbon Capital (https://lowercarboncapital.com/) Lionheart Ventures (https://lionheart.vc/) Happines Capital (https://www.happinesscapital.com/) Grazia Equity (https://grazia.com/de/) Good Seed Ventures (https://goodseedventures.com/) EQT Capital (https://eqtgroup.com/) Elevat3 Capital (https://elevat3.vc/)
Investors: Patient Square Capital (https://patientsquarecapital.com/) Rock Springs Capital (http://www.rockspringscapital.com/) Reimagined Ventures (https://reimaginedventures.com/) UCL Technology Fund (https://www.ucltf.co.uk/)
Investors: Athos Group (http://www.athosgroup.com/) Cargill (https://www.cargill.com/home) E.R. Capital Holdings MIG (http://www.mig.ag/en/) Novo Holdings (https://www.novoholdings.dk/)
